Istituto Nazionale per lo studio e la cura dei tumori Fondazione Giovanni Pascale

Naples 80131

1 studies enrolling now · 6 studies all time

What they study most

BRAF or NRAS Mutant Metastatic Melanoma, Colorectal Cancer (CRC), Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV, Neoplasms, Ovarian Cancer, Solid Tumors Harboring a BRAF V600 Mutation

Studies at this site

• Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells — Recruiting now
• Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation — Completed
• A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors — Completed
• A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma — Completed
• Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence — Stopped early
• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early